Arrowhead Pharmaceuticals Inc (ARWR)
Financial leverage ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total assets | US$ in thousands | 626,286 | 765,552 | 795,856 | 891,308 | 891,489 | 691,939 | 751,782 | 703,575 | 638,539 | 710,148 | 734,927 | 756,795 | 499,251 | 522,504 | 555,728 | 561,076 | 587,602 | 349,845 | 336,828 | 333,940 |
Total stockholders’ equity | US$ in thousands | 160,407 | 271,343 | 364,830 | 446,772 | 377,039 | 398,520 | 453,927 | 452,266 | 372,560 | 408,822 | 436,890 | 445,549 | 454,472 | 461,779 | 493,140 | 494,119 | 500,084 | 244,591 | 226,225 | 201,195 |
Financial leverage ratio | 3.90 | 2.82 | 2.18 | 1.99 | 2.36 | 1.74 | 1.66 | 1.56 | 1.71 | 1.74 | 1.68 | 1.70 | 1.10 | 1.13 | 1.13 | 1.14 | 1.18 | 1.43 | 1.49 | 1.66 |
December 31, 2023 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $626,286K ÷ $160,407K
= 3.90
Arrowhead Pharmaceuticals Inc.'s financial leverage ratio has been trending upward over the past eight quarters, reflecting an increasing level of financial leverage. The ratio has seen a significant increase from 1.56 in Q2 2022 to 3.90 in Q1 2024. This indicates that the company's reliance on debt to finance its operations and growth has been on the rise.
The upward trend in the financial leverage ratio suggests that Arrowhead Pharmaceuticals Inc. has been taking on more debt relative to its equity, which could potentially amplify returns during periods of growth but also increase financial risk. A higher financial leverage ratio indicates a higher level of debt financing compared to equity, which can lead to higher interest payments and lower financial flexibility.
While a certain level of financial leverage can be beneficial in optimizing capital structure and lowering the cost of capital, it is important for Arrowhead Pharmaceuticals Inc. to carefully manage its debt levels to avoid financial distress during economic downturns or adverse business conditions. Monitoring the financial leverage ratio over time can provide insights into the company's capital structure decisions and overall financial risk profile.
Peer comparison
Dec 31, 2023